$226.00+11.68% · 3M
Moving avg
1W+0.88%
1M+13.85%
3M+11.68%
6M-12.95%
YTD-7.68%
1Y-20.22%
3Y+24.97%
5Y-17.88%
52-week range
$180.2740% of range$293.81
Company health
Value2/6
Growth4/6
Profitability6/6
Health6/6
Dividend5/6
Bull vs bear
Strengths
- Strong 27% net margin
- High return on equity (2441%)
- Revenue compounding 11% a year
- Net cash on the balance sheet
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$32.78B
Enterprise value
$28.64B
P/E ratio (TTM)
19.56x
P/S ratio (TTM)
5.32x
EV/EBITDA
13.10x
Per share & returns
EPS (TTM)
$10.37
Dividend yield
1.18%
Beta (1Y)
0.78
30-day change
+13.85%
Trading
Volume (24h)
1.05M
Previous close
$224.84
Shares outstanding
145.06M
About ResMed Inc.
Sector
Healthcare
Industry
Medical - Devices
Exchange
NYSE
Symbol
RMD
ResMed Inc. is a large-cap healthcare company in the Medical - Devices industry. Its shares are listed on NYSE (United States) and trade under the ticker RMD.
Frequently asked questions
What is ResMed Inc.'s market cap?
ResMed Inc. (RMD) has a market capitalization of $32.78B.
What is ResMed Inc.'s P/E ratio?
ResMed Inc. trades at a price-to-earnings (P/E) ratio of 19.56.
What exchange does RMD trade on?
RMD trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.92B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.41B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap